Success Milestone definition

Success Milestone has the meaning set out in Clause 13.1.1;
Sample 1Sample 2Sample 3
Success Milestone shall have the meaning set forth in Section 3.2
Sample 1Sample 2Sample 3
Success Milestone means actual receipt by Licensor of at least six million U.S. dollars ($6,000,000) paid by Licensee pursuant to Section 5.1 and Section 7.1.
Sample 1Sample 2

Examples of Success Milestone in a sentence

  • Company may terminate this Agreement effective ninety (90) days following such written notice to Receptos unless Receptos identifies to Company within such ninety (90) days a reasonable non-infringing means of practicing the Technology License which avoids such suggested infringement of such Third Party intellectual property rights, and in the event of such a termination, Company shall not be obligated to pay the Success Milestone, unless the Success Milestone became due prior to date of such notice.

  • Company shall have the right, in its sole discretion, to pay the Success Milestone prior to January 1, 2012.

  • The reference to “buy out” in this Clause shall mean that CRT shall cease to be entitled to Royalties or Success Milestone Payments in exchange for some other cash consideration.

  • In connection with the achievement of the Collaboration Success Milestone, Novartis shall pay, or cause to be paid, to Alnylam the amount of [**] dollars ($[**]).

  • Unless earlier terminated in accordance with the provisions set forth herein this Agreement will remain in effect from the Effective Date until the earlier of (i) the three (3) year anniversary of the Effective Date (the “Term”) or (ii) the later of (x) achievement of Tech Transfer Success; (y) delivery of the Tech Transfer Deliverables; and (z) payment of Success Milestone.

  • Company is under no obligation to conduct research, development, or commercialization activities relating to any Receptos Technology, Tech Transfer Target, or GPCR; provided that so long as the Success Milestone has not been paid, this Section 4.3 shall not relieve Company from its obligations herein to cooperate with Receptos with respect to achievement of Tech Transfer Success.

  • For clarity, even if the amount of Net Sales of Products is greater than sixty million dollars ($60,000,000) in more than one calendar year, Buyer will only be required to make the Success Milestone payment one time.

  • The term of this Agreement will begin on the Effective Date and will expire, in its entirety, on the Expiration Date (the “Initial Term”) unless earlier terminated under the provisions of this Section 7; provided however that, the Initial Term shall automatically extend for an additional two and a half (2.5) years (the “Renewal Term”, together with the Initial Term, the “Term”) if the Success Milestone has been met during the Initial Term.

  • Executive Vice President, People Success, Milestone Technologies 2016–2017.

  • If Genentech, despite using Commercially Diligent Efforts, is not successful in achieving the results required for a Success Notice 1 or Success Notice 2 for a given Designated Gene, no Success Milestone Payment shall be due for such Designated Gene.


More Definitions of Success Milestone

Success Milestone means that the Company shall have (i) achieved the results outlined in the 90-Day Operating Plan adopted by the Company and attached hereto as Exhibit A, and (ii) consummated a sale, merger or a material strategic transaction (as determined by the Board of Directors). Should the Company exercise its right to terminate this Agreement as set forth herein, for a period of six month following such termination, any Success Milestone achieved by the Company shall entitle CTA to the Success Fee as if this Agreement was still in effect. The provisions of this paragraph shall survive any termination of this Agreement in accordance with the terms hereof. In addition to the monthly fees and the Success Fee contemplated above, the Company shall reimburse CTA for all reasonable out-of-pocket expenses incurred by CTA in connection with CTA's obligations under this Agreement upon presentation to the Company of appropriate supporting documentation relating to such expenses. All expense reimbursement hereunder shall be made to CTA within a commercially reasonable time period upon the presentation of such documentation to the Company.
Sample 1Sample 2
Success Milestone. A [***] of at least [***] which meets the targets and specifications described in the “Requirements and Scale” section above, unless process development data justifies an exception, will be the basis for a milestone payment of $500,000 if this is accomplished within [***] of the initiation of Stage 1 work with the projected number of FTEs. ImmunoGen will provide formal notification of initiation of Stage 1 work within [***] of execution of the Amendment. If the [***] is delayed due to factors controlled by sanofi-aventis, such as not receiving the needed materials or analytical data from sanofi-aventis, this date may be modified by mutual agreement. STAGE IV: [***] Purpose: [***]. Activities: IMGN: [***] Portions of the exhibit, indicated by the xxxx “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. [***] [***] [***] [***] S-A: [***] [***] [***] [***] [***] Deliverables: [***]. Duration: Assuming [***], transfer of [***] should be complete [***] from start of transfer IMGN FTE: Depending on scope, average of [***] FTE’s in Process and [***] FTE’s in Analytical (may not be evenly distributed over duration of this phase of project). Portions of the exhibit, indicated by the xxxx “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended Total FTE Requirement at ImmunoGen Stages I — IV (up to and including [***]) are estimated to take [***]. Average of [***] FTE in Process Science and Engineering (includes [***] and [***]) Average of [***] FTE in Analytical and Pharmaceutical Sciences (analytical resources only) Estimated Materials Requirements (Stages I — IV) Ab (gm) DM4 (gm) SPDB (gm) Month [***] [***] [***] [***] Month [***] [***] [***] [***] Month [***] [***] [***] [***] Month [***] [***] [***] [***] Month [***] [***] [***] [***] It is understood that sanofi-aventis intends to provide these materials. If necessary, ImmunoGen would be able to provide DM4 at a cost of $[***] per [***], but would not be obligated to provide any amount in excess of [***] Travel Expenses Expenses for [***] personnel to travel to [***] for [***] will be paid by [***] and will require prior approval of...
Sample 1
Success Milestone. A demonstration batch of at least 2g scale which meets the targets and specifications described in the “Requirements and Scale” section above, unless process development data justifies an exception, will be the basis for a milestone payment of $500,000 if this is accomplished within ten months of the initiation of Stage 1 work with the projected number of FTEs. ImmunoGen will provide formal notification of initiation of Stage 1 work within 4 weeks of execution of the Amendment. If the demonstration batch is delayed due to factors controlled by sanofi-aventis, such as not receiving the needed materials or analytical data from sanofi-aventis, this date may be modified by mutual agreement.
Sample 1
Success Milestone means actual receipt by Licensee of at least one hundred million U.S. dollars ($100,000,000) in Sublicense Fees from its Sublicensees, including but not limited to upfront fees, milestone payments, royalties and other amounts.
Sample 1
Success Milestone means actual receipt by Licensor of at least six million U.S. dollars ($6,000,000) paid by Licensee pursuant to Section 5.1.” iii. Section 2.2 (Sublicensing.) is amended by replacing “twenty million dollars ($20,000,000) in cash” with “that does not have at least ten million dollars ($10,000,000) in cash”. iv. Section 5.1 (
Sample 1
Success Milestone means actual receipt by Licensee of at least $100 million from the Opportunity Sublicenses, including but not limited to upfront fees, milestone payments, royalties and other amounts.
Sample 1

Related to Success Milestone

  • Milestone 1 means achievement of annual Net Sales of at least $20,000,000 during the Calendar Year ending on December 31, 2021.

  • Milestone Date means the date set against the relevant Milestone in the Implementation Plan;

  • Development Milestone Event shall have the meaning set forth in Section 9.2(a).

  • Milestone means an event or task described in the Implementation Plan which must be completed by the corresponding date set out in such plan;

  • Milestone Event has the meaning set forth in Section 8.4.

  • Project Milestone means the project milestone set forth in Schedule-J;

  • Sales Milestone Payment shall have the meaning set forth in Section 8.4.

  • Milestone 2 means achievement of annual Net Sales of at least $35,000,000 during any Calendar Year ending on or before December 31, 2024.

  • Development Milestone Payment shall have the meaning set forth in Section 9.2(a).

  • Performance Milestone means an act or event specified in section 5.1 and described in section 9 of the EPLA.

  • Milestone Dates means the dates for completion of specified Project activities as contained in the Project Schedule.

  • Milestone Events has the meaning set forth in Section 3.3 (Milestone Payments).

  • Project Milestones means the project milestones set forth in Schedule-G;

  • Milestone Payment Date has the meaning set forth in Section 2.4(a).

  • Milestone Payment means a payment identified in the Implementation Plan to be made following the issue of a Satisfaction Certificate in respect of Achievement of the relevant Milestone;

  • Milestones means control points in the project that help to chart progress. Milestones may correspond to the completion of a key deliverable, allowing the next phase of the work to begin. They may also be needed at intermediary points so that, if problems have arisen, corrective measures can be taken. A milestone may be a critical decision point in the project where, for example, the consortium must decide which of several technologies to adopt for further development.

  • Milestone Schedule means Seller’s milestone schedule, the form of which is attached to this Agreement as Exhibit Q.

  • EBITDA Target means the Company's projected earnings before interest, taxes, one-time transition expenses, non-cash compensation expense charges, depreciation and amortization, as contained in the Company's budget for the Applicable Period and which is approved by the Board (without reference to any adjustments or revision, upwards or downwards, to such projected earnings which are subsequently approved by the Board as part of any subsequent revision to such budget), and (ii) the term "Financial Results" shall mean the Company's EBITDA calculated by reference to the Company's financial statements for the Applicable Period as filed with the Securities and Exchange Commission (the "SEC").

  • Design Criteria Package means concise, performance-oriented drawings or specifications for a public construction project. The purpose of the Design Criteria Package is to furnish sufficient information to permit Design-Build Firms to prepare a bid or a response to the District’s Request for Proposals, or to permit the District to enter into a negotiated Design- Build Contract. The Design Criteria Package must specify performance- based criteria for the public construction project, including the legal description of the site, survey information concerning the site, interior space requirements, material quality standards, schematic layouts and conceptual design criteria of the project, cost or budget estimates, design and construction schedules, site development requirements, provisions for utilities, stormwater retention and disposal, and parking requirements applicable to the project. Design Criteria Packages shall require firms to submit information regarding the qualifications, availability, and past work of the firms, including the partners and members thereof.

  • KPI Target means the acceptable performance level for a KPI as set out in each KPI;

  • Initial Indication means the treatment of Netherton Syndrome in humans in the Territory.

  • Semi-annual (2/Year) sampling frequency means the sampling shall be done during the months of June and December, unless specifically identified otherwise.

  • Soft Target means a target that will suffer minimum damage and cause minimum damage to the subject vehicle in the event of a collision.

  • Milestone Failure means a failure by the Grant Recipient fully to achieve any Milestone by the relevant Milestone Date;

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Yearly (1/Year) sampling frequency means the sampling shall be done in the month of September, unless specifically identified otherwise in the effluent limitations and monitoring requirements table.